176 related articles for article (PubMed ID: 27336583)
21. Synthesis and antibacterial activity of some ester, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins.
Bellomo P; Marchi E; Mascellani G; Brufani M
J Med Chem; 1981 Nov; 24(11):1310-4. PubMed ID: 7310806
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
Trampuz A; Murphy CK; Rothstein DM; Widmer AF; Landmann R; Zimmerli W
Antimicrob Agents Chemother; 2007 Jul; 51(7):2540-5. PubMed ID: 17502404
[TBL] [Abstract][Full Text] [Related]
23. In vitro time-kill activities of rifalazil, alone and in combination with vancomycin, against logarithmic and stationary cultures of Staphylococcus aureus.
Osburne MS; Rothstein DM; Farquhar R; Murphy CK
J Antibiot (Tokyo); 2006 Feb; 59(2):80-5. PubMed ID: 16629407
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of novel rifamycins against gram-positive clinical isolates.
Murphy CK; Karginova E; Sahm D; Rothstein DM
J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
[TBL] [Abstract][Full Text] [Related]
25. Current use for old antibacterial agents: polymyxins, rifamycins, and aminoglycosides.
Chen LF; Kaye D
Infect Dis Clin North Am; 2009 Dec; 23(4):1053-75, x. PubMed ID: 19909897
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and evaluation of 1-(1H-indol-3-yl)ethanamine derivatives as new antibacterial agents.
Burchak ON; Pihive EL; Maigre L; Guinchard X; Bouhours P; Jolivalt C; Schneider D; Maurin M; Giglione C; Meinnel T; Paris JM; Denis JN
Bioorg Med Chem; 2011 May; 19(10):3204-15. PubMed ID: 21515059
[TBL] [Abstract][Full Text] [Related]
27. Activity of novel benzoxazinorifamycins against rifamycin-resistant Streptococcus pyogenes.
Mullin S; Rothstein DM; Murphy CK
Antimicrob Agents Chemother; 2006 May; 50(5):1908-9. PubMed ID: 16641476
[No Abstract] [Full Text] [Related]
28. Synthesis and antibacterial activity of novel enolphosphate derivatives.
Grison C; Barthes N; Finance C; Duval RE
Bioorg Chem; 2010 Oct; 38(5):218-23. PubMed ID: 20655569
[TBL] [Abstract][Full Text] [Related]
29. 8-Deoxy-Rifamycin Derivatives from
Ye F; Shi Y; Zhao S; Li Z; Wang H; Lu C; Shen Y
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32887371
[TBL] [Abstract][Full Text] [Related]
30. Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.
Ma Z; He S; Yuan Y; Zhuang Z; Liu Y; Wang H; Chen J; Xu X; Ding C; Molodtsov V; Lin W; Robertson GT; Weiss WJ; Pulse M; Nguyen P; Duncan L; Doyle T; Ebright RH; Lynch AS
J Med Chem; 2022 Mar; 65(6):4481-4495. PubMed ID: 35175750
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antibacterial activity of novel modified 5-O-mycaminose 14-membered ketolides.
Xu Y; Chen X; Zhu D; Liu Y; Zhao Z; Jin L; Liu C; Lei P
Eur J Med Chem; 2013 Nov; 69():174-81. PubMed ID: 24021890
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and study of 1-ethyl-3-carbohydrazide and 3-[1-oxo-2-hydrazino-3-{p-toluenesulfon}]quinolone derivatives against bacterial infections.
Srivastava N; Kumar A
Eur J Med Chem; 2013 Sep; 67():464-8. PubMed ID: 23933534
[TBL] [Abstract][Full Text] [Related]
33. A Comparative Insight on the Newly Emerging Rifamycins: Rifametane, Rifalazil, TNP-2092 and TNP-2198.
Nazli A; He DL; Xu H; Wang ZP; He Y
Curr Med Chem; 2022; 29(16):2846-2862. PubMed ID: 34365945
[TBL] [Abstract][Full Text] [Related]
34. Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
Li X; Hilgers M; Cunningham M; Chen Z; Trzoss M; Zhang J; Kohnen L; Lam T; Creighton C; G C K; Nelson K; Kwan B; Stidham M; Brown-Driver V; Shaw KJ; Finn J
Bioorg Med Chem Lett; 2011 Sep; 21(18):5171-6. PubMed ID: 21831637
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases.
Czerwonka D; Domagalska J; Pyta K; Kubicka MM; Pecyna P; Gajecka M; Przybylski P
Eur J Med Chem; 2016 Jun; 116():216-221. PubMed ID: 27061985
[TBL] [Abstract][Full Text] [Related]
36. Preparation of 8-hydroxyquinoline derivatives as potential antibiotics against Staphylococcus aureus.
Lam KH; Gambari R; Lee KK; Chen YX; Kok SH; Wong RS; Lau FY; Cheng CH; Wong WY; Bian ZX; Chan AS; Tang JC; Chui CH
Bioorg Med Chem Lett; 2014 Jan; 24(1):367-70. PubMed ID: 24269165
[TBL] [Abstract][Full Text] [Related]
37. The Enzymes of the Rifamycin Antibiotic Resistome.
Surette MD; Spanogiannopoulos P; Wright GD
Acc Chem Res; 2021 May; 54(9):2065-2075. PubMed ID: 33877820
[TBL] [Abstract][Full Text] [Related]
38. Discovery of bisindolyl-substituted cycloalkane-anellated indoles as novel class of antibacterial agents against S. aureus and MRSA.
El-Sayed MT; Suzen S; Altanlar N; Ohlsen K; Hilgeroth A
Bioorg Med Chem Lett; 2016 Jan; 26(1):218-21. PubMed ID: 26590101
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of diverse analogues of Oenostacin and their antibacterial activities.
Srivastava V; Darokar MP; Fatima A; Kumar JK; Chowdhury C; Saxena HO; Dwivedi GR; Shrivastava K; Gupta V; Chattopadhyay SK; Luqman S; Gupta MM; Negi AS; Khanuja SP
Bioorg Med Chem; 2007 Jan; 15(1):518-25. PubMed ID: 17035037
[TBL] [Abstract][Full Text] [Related]
40. Rifamycin S and its geometric isomer produced by a newly found actinomycete, Micromonospora rifamycinica.
Huang H; Wu X; Yi S; Zhou Z; Zhu J; Fang Z; Yue J; Bao S
Antonie Van Leeuwenhoek; 2009 Feb; 95(2):143-8. PubMed ID: 19125348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
